Thursday, December 19, 2024
Home Institutional Analyst Newsletter Page 39

Institutional Analyst Newsletter

    Latest
    OMQS

    Adding OmniQ (OMQS) $5.00 to the Watch List.

    Cybersecurity Editor / Curator -
    Artificial Intelligence (AI) Fans Take a Peek. This is our Latest Attempt at...
    Hapbee

    Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

    Telehealth Editor / Curator -
    Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...

    Adding Galaxy Digital (GLXY) $5.19 to Watch List.

    Institutional Analyst Newsletter Editor / Curator -
    Here's your back-door into Bitcoin, which as you are probably aware is on a tear once again (see chart below). News of...
    Hapbee, Biotech Stock Review

    Telehealth App Hapbee (HAPB) Goes Public and More.

    Institutional Analyst Newsletter Editor / Curator -
    1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
    Hapbee,

    Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

    All News Editor / Curator -
    VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
    Dalarada Health, Biotech Stock Review

    Dalrada Cervical Cancer Testing Kit Study.

    Institutional Analyst Newsletter Editor / Curator -
    KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE
    biotech stock review

    Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

    Institutional Analyst Newsletter Editor / Curator -
    DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
    Issam Radd

    Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

    2020 Watch List Editor / Curator -
    2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone...
    Biosig

    Adding BioSig (BSMG) $2.95 to Watch List.

    Biotech News Editor / Curator -
    Tough setback for newly launched Anti-Viral Endeavor ViralClear, Back to the Business of PURE EP™. LIVE...
    Hepion, Biotech Stock Review

    Hepion Pharma (HEPA): News Archive

    CoronaVirus Editor / Curator -
    UPDATED CONTINUOUSLY.. 12/31/2020: News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10. 12/23/2020: Remember...
    1...383940...53Page 39 of 53

    Latest article

    Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

    All News Editor / Curator -
    119% Gain Post Split

    Nine Page Summary Report on GeoVax (GOVX)

    Institutional Analyst Newsletter Editor / Curator -
    This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

    GeoVax (GOVX) Provides First Half 2024 Business Update.

    Institutional Analyst Newsletter Editor / Curator -
    Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.